Role of RAS signaling in ovarian cancer [version 1; peer review: 2 approved]
The RAS family of proteins is among the most frequently mutated genes in human malignancies. In ovarian cancer (OC), the most lethal gynecological malignancy, RAS, especially KRAS mutational status at codons 12, 13, and 61, ranges from 6–65% spanning different histo-types. Normally RAS regulates sev...
Main Authors: | Hesham M. Korashy, Shahab Uddin, Abdullah Azmi, Ajaz Bhat, Lubna Therachiyil, Anjana Anand |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2022-11-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/11-1253/v1 |
Similar Items
-
Ras and Ras mutations in cancer
by: Rajasekharan Satish, et al.
Published: (2013-07-01) -
RAS family GTPases /
by: Der, Channing J.
Published: (2006) -
The Ins and Outs of RAS Effector Complexes
by: Christina Kiel, et al.
Published: (2021-02-01) -
Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives
by: Renata Tisi, et al.
Published: (2020-11-01) -
O PROTO-ONCOGENE RAS NO BÓCIO MULTINODULAR
by: Lenara Golbert, et al.
Published: (2022-07-01)